Part-Time Online Pathologist
admin@pathologynews.com2024-06-12T09:17:32+00:00RemotePart time United States
RemotePart time United States
On-siteHistoWiz Inc.Full time New York, New York, United States
Quest Diagnostics, a leader in diagnostic information services, today announced that it has completed its previously announced acquisition of PathAI Diagnostics from PathAI, with the goal to accelerate the adoption of AI and digital pathology to improve the diagnosis of cancer and other diseases.
On-siteHistoWiz Inc.Full time Long Island City, New York, United States
On-siteHistoWiz Inc.Full time Long Island City, New York, United States
In a new study, researchers at the University of Naples and the University of Molise developed a deep learning model to predict Ki-67 immunohistochemical staining from hematoxylin-eosin (H&E)-stained images of oral cancer samples. After training the model on H&E- and Ki-67 image pairs, researchers used it to predict Ki-67 in routine slides.
Part four of our series on the Digital Pathology and Ai Congress: USA discuss the recent advances in digital pathology including new slide-free and label-free imaging techniques, such as Fluorescence Imitating Brightfield Imaging (FIBI) and Quantitative Oblique Back-Illumination Microscopy (qOBM).
Dr. Richard Levenson joins the Digital Pathology Podcast for an insightful discussion on innovations in digital pathology. With an eclectic background spanning the humanities, pathology research, and experience in startups, Richard offers a unique perspective. He is currently pioneering groundbreaking research in glassless pathology techniques and AI applications at UC Davis Health.
The reports provide a comprehensive overview of the digital pathology implementation experiences at the University of Michigan and Mayo Clinic, showcasing the benefits, challenges, and future potential of digital and AI technologies in pathology.
Aiosyn, a medical software company specializing in AI-powered pathology solutions for cancer and kidney diseases, recently conducted a clinical performance study in collaboration with Radboud university medical center. This study evaluated the benefits of Aiosyn Mitosis Breast for mitotic figure detection in clinical settings. Following the presentation at the USCAP 113th Annual Meeting, these results will be showcased at the 20th European Congress on Digital Pathology.
© Copyright 2025, Bioincyte Ltd
PathologyNews Chat
